No Added Mobility Benefit to Inpatient PT Rehab Post-TKR for OA
Data from the Osteoarthritis Initiative show that total knee replacement has minimal effects on quality of life among patients with knee osteoarthritis.
All articles by Lauren Grygotis, Editor
ACGME: First-year Residents Can Work 24-hour Shifts
Residency programs can increase shift hours for first-year residents from 16 to 24 hours, ACGME says.
Pneumonia Vaccine Effectiveness Questioned in Rheumatoid Arthritis Patients
Study authors say results indicate vaccine may not be effective for pneumonia in patients with rheumatoid arthritis at high risk for infections.
USPSTF Updates Statin Prevention Guidelines
Adults between 40 and 75 years of age without a history of CVD should use a low- to moderate-dose statin to prevent CVD events.
Symptom-Guided Methodology to Earlier Detect IA in General Practice
Consultations for musculoskeletal symptoms increase and become statistically significant around 1.5 years preceding diagnosis of inflammatory arthritis.
Are Government-Protected Monopolies Driving Up Rx Costs?
The increasing cost of prescription drugs in the United States has important clinical implications and consequences.
Is There Sufficient Evidence to Specify Limits of Sedentary Time? AHA Weighs In
The American Heart Association updated its science advisory covering the cardiovascular risks associated with sedentary behavior.
Is Post-Vaccination IgG Predictive of Mortality in Systemic Vasculitis?
Low IgG and B cell counts were associated with infection and vaccine response among patients with systemic vasculitis in stable remission.
Optimal Depression, Anxiety Short Form Screening Threshold in RA
The SF-36 health survey can accurately determine the presence of psychological disorders in patients with RA, and suggests that a threshold of ≤38 on the mental component summary score may be optimal to screen for these disorders.
Calprotectin vs Acute-Phase Reactants to Discriminate RA, PsA Activity
Calprotectin discriminate disease activity in patients with RA receiving tumor necrosis factor inhibitors more effectively than acute-phase reactants.
- Loading...
Loading...
Loading... 
Loading...